Testing a painless scan to study liver spots in cirrhosis
Part of Digestive system clinical trials.
This trial studies “focal liver lesions,” meaning specific spots in the liver, using a non-invasive (no surgery or biopsy) approach. It may help doctors better understand what these spots are in people who have cirrhosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cirrhosis (scarring of the liver).
- You have one or more specific spots (“focal liver lesions”) seen in your liver.
- You are able and willing to sign consent to join the study.
- You must be 18 years or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.
This study is looking for a better way to diagnose and track chronic liver disease without invasive procedures like biopsies. If you join, researchers will use simple tests (like blood tests or imaging) to see how well they predict the progression of your liver condition.
This study compares two non-invasive approaches to diagnose advanced liver scarring in people with non-alcohol-related fatty liver disease (NAFLD). It may help confirm which test strategy finds advanced scarring without needing a biopsy for everyone.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study looks at how your body uses protein in your muscles when you have cirrhosis (a scarred liver). It uses a special “tracer” method (a substance that can be tracked) and may help researchers better understand muscle loss in people with milder cirrhosis.
This study is testing a new way to use a FibroScan (a non-invasive liver scanner) with a single probe to measure liver health in people with chronic liver disease. If you have a long-term liver condition, this trial may help improve how liver exams are done.
Hear when a new Liver Cirrhoses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.